Anticipated Shortage

TYENNE

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TYENNE in Canada?

A shortage of TYENNE 80MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated August 21, 2026), but it has not started yet.

Why is TYENNE not available?

The reason the manufacturer reported: Demand increase for the drug.

When will TYENNE be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusAnticipated Shortage

Same-ingredient products on file2 products

Affected strength80MG

Last updated2026-08-21

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AVTOZMA

CELLTRION INC.

80MG · DIN 02562022

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

ACTEMRA

HOFFMANN-LA ROCHE LIMITED

400MG · DIN 02350114

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02552450

Strength

80MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

TOCILIZUMAB

Tier

Unrated

Last Updated

2026-08-21

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482